HIV, Trump and South Africa
Trump's Aid Cuts Stop South African HIV Vaccine Trials in Their Tracks
South African lab technician Nozipho Mlotshwa was waiting for the test results for a potential HIV vaccine, which has eluded scientists for decades, when the order came from USAID to stop work. The first round of vaccines she and her colleagues made in Johannesburg had produced an immune response in rabbits,
In Africa, a U.S. funding loss will be critical to HIV programs in countries like Uganda, Mozambique and Tanzania.
in sub-Saharan Africa could be an ... Nov. 25, 2024 — A new study reveals significant progress in the global fight against HIV/AIDS, alongside a stark warning that current trends indicate the ...
whose funding is now in question after Trump suspended the President’s Emergency Plan for AIDS Relief, or PEPFAR. It contributes more than $400 million a year to South Africa’s HIV programs ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback